We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) (EMERGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03812796
Recruitment Status : Unknown
Verified February 2019 by Royal Marsden NHS Foundation Trust.
Recruitment status was:  Recruiting
First Posted : January 23, 2019
Last Update Posted : February 5, 2019
Sponsor:
Collaborators:
4SC AG
Merck KGaA, Darmstadt, Germany
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : November 30, 2021